Agilent Shares Up 8 Percent on Strong Growth in Q3 Revenue, Profit | GenomeWeb
NEW YORK (GenomeWeb News) – Shares in Agilent were up 8.14 percent, or $2.32, at $30.79 in mid-afternoon trading after the company yesterday reported a surge in third-quarter revenue and profit.
 
As GenomeWeb News reported this morning, Agilent said total revenues for the three months ended June 30 increased 17 percent to $1.45 billion from $1.24 billion in the same quarter last year. The company’s net income rose 118 percent to $227 million from $104 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.